---
figid: PMC9256076__IJO-61-2-05383-g00
pmcid: PMC9256076
image_filename: IJO-61-2-05383-g00.jpg
figure_link: /pmc/articles/PMC9256076/figure/f1-ijo-61-2-05383/
number: Figure 1
figure_title: ''
caption: Metabolic pathways utilized by pancreatic cancer cells. Upward arrows represent
  upregulation and T-bars represent inhibition. Red lettering indicates deregulated
  genes, proteins and processes. ACS, acetyl-CoA synthetase; Arg, arginine; ASCT2,
  alanine serine cysteine transporter 2; Asp, aspartate; BCAAs, branched-chain amino
  acids; BCAT1/2, branched-chain aminotransferase 1/2; BCKAs, branched-chain keto
  acids; CPSII, carbamoyl phosphate synthase II; EMT, epithelial-mesenchymal transition;
  F-1,6BP, fructose 1,6-bisphosphate; F-6P, fructose 6-phosphate; FA, fatty acid;
  FASN, fatty acid synthase; G-6P, glucose 6-phosphate; GFAT, glutamine fructose-6-phosphate
  amidotransferase; GlcN-6P, glucosamine-6-phosphate; Gln, glutamine; GLS1/GLS2, glutaminase
  1/2; Glu, glutamate; GLUT1, glucose transporter 1; GOT1/GOT2, glutamate oxaloacetate
  transaminase 1/2; GPAT, glycerol-3-phosphate acyltransferase; GSH, glutathione;
  GSSG, glutathione disulfide; HIF1α/HIF2α, hypoxia-inducible factor 1-α/2-α; HIF1β,
  hypoxia-inducible factor 1-β; HK1/2, hexokinase 1/2; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme
  A reductase; Farnesyl-PP, farnesyl pyrophosphate; Ile, isoleucine; LDLR, low-density
  lipoprotein receptor; Leu, leucine; lncRNA XLOC_006390, long non-coding RNA XLOC_006390;
  MCT1/MCT4, monocarboxylate transporter 1/4; ME2, malic enzyme 2; ME3, malic enzyme
  3; mTORC1/mTORC2, mechanistic target of rapamycin complex 1/2; MUFA, monounsaturated
  fatty acid; Mutp53, mutant p53; NAD+, nicotinamide adenine dinucleotide; NADH, reduced
  form of nicotinamide adenine dinucleotide; NADP+, nicotinamide adenine dinucleotide
  phosphate; NADPH, reduced form of nicotinamide adenine dinucleotide phosphate; NEAA,
  non-essential amino acids; NO, nitric oxide; OAA, oxaloacetate; PDH, pyruvate dehydrogenase;
  PFK1, phosphofructokinase-1; Pi, inorganic phosphate; PI3K, phosphoinositide 3-kinase;
  PKM2, pyruvate kinase M2; PPP, pentose phosphate pathway; PUFA, polyunsaturated
  fatty acid; SCD1, stearoyl-CoA desaturase 1; SFA, saturated fatty acid; UB, ubiquitin;
  UCP2, uncoupling protein 2; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine;
  Val, valine; α-KG, α-ketoglutarate.
article_title: Cellular metabolism in pancreatic cancer as a tool for prognosis and
  treatment (Review).
citation: Michal Zuzčák, et al. Int J Oncol. 2022 Aug;61(2):93.
year: '2022'

doi: 10.3892/ijo.2022.5383
journal_title: International Journal of Oncology
journal_nlm_ta: Int J Oncol
publisher_name: D.A. Spandidos

keywords:
- pancreatic cancer
- metabolic profiling
- glycolysis
- amino acid metabolism
- mitochondrial oxidative metabolism
- tumor microenvironment
- cancer stem cells
- cell metabolism
- chemoresistance

---
